News / Events

Featured News Stories

  • June 11, 2009

    JUBLIANT TO WORK WITH ENDO PHARMACEUTICALS ON DRUG DEVELOPMENT
    Collaboration to provide Endo Pharmaceuticals with new drug candidates in Oncology
    Download PDF | View Short Summary

    NOIDA, INDIA (June 11, 2009) - Jubilant Organosys Ltd., headquartered in Noida, announced today that its Bangalore-based subsidiary, Jubilant Biosys Ltd., has entered into a discovery and development collaboration with Endo Pharmaceuticals, a US-based pharmaceutical company. As part of the agreement, Jubilant and Endo would collaborate initially to develop a portfolio of targets in the area of Oncology, with a focus on delivering preclinical candidates that could be selected for joint clinical development.

  • June 10, 2009

    TRIALSTAT FEATURED IN THE OTTAWA BUSINESS JOURNAL
    View Article

  • May 5, 2009

    JUBILANT ENTERS RESEARCH COLLABORATION WITH ASTRAZENECA
    Research collaboration to provide AstraZeneca with new preclinical drug candidates
    Download PDF | View Short Summary

    NOIDA, INDIA (May 5, 2009) - Jubilant Organosys Ltd, headquartered in India, announced today that its Bangalore, India, based subsidiary,Jubilant Biosys Ltd, has signed a research collaboration agreement with, AstraZeneca, and focused on delivering novel drug candidates into the international pharmaceutical company's pre-clinical pipeline. Under the shared risk-reward collaboration, which will initially focus on the neuroscience area, Jubilant aims to deliver a steady stream of discovery programs to AstraZeneca.

    AstraZeneca will own the compounds developed under the collaboration with worldwide development and commercialization rights. Jubilant will be eligible to receive research funding spanning an initial five-year period. In addition, AstraZeneca will also pay Jubilant success-based development milestones, as well as royalties based on successful global commercialization of any of the compounds.

  • March 18, 2009

    CLINSYS PARTNERS WITH NC STATE FOR SIX SIGMA GREEN BELT TRAINING
    Download PDF | View Short Summary

    BEDMINSTER, NEW JERSEY (March 18, 2009) - Clinsys Clinical Research, Inc.®, a therapeutically focused global contract research organization, announced its partnership with North Carolina State University (NCSU) to provide 20 Clinsys employees with Six Sigma Green Belt training. During the month of March, these employees will participate in a two-part training program directed by NCSU's College of Textiles and Industrial Extension Service (IES) departments.

  • March 16, 2009

    CLINSYS CEO DAVID WILLIAMS NAMED 2009 TOP BUSINESS LEADER
    View Article

  • January 26, 2009

    CLINSYS ECSTATIC OVER TRIALSTAT CA EDC ACQUISITION
    View Article

  • January 29, 2009

    KIMMEL APPOINTED AS ACADEMY CHAIR OF ACRP
    Download PDF | View Short Summary

    BEDMINSTER, NEW JERSEY (January 29, 2009) - Clinsys Clinical Research, Inc.®, a therapeutically focused global contract research organization, announced the appointment of Kathryn Kimmel, CCRC, CCRA, a Senior Clinical Research Associate (CRA), as chair of the Academy Board of Trustees for the Association of Clinical Research Professionals (ACRP). The Academy oversees ACRP certification functions related to members who are CRAs, clinical research coordinators (CRCs) and nonphysician clinical trial investigators (CTIs).

  • January 26, 2009

    CLINSYS ECSTATIC OVER TRIALSTAT CA EDC ACQUISITION
    View Article

  • December 8, 2008

    CLINSYS ENTERS EDC NICHE
    View Article

  • November 18, 2008

    CLINPAGE DISCUSSES STRATEGY BEHIND CLINSYS' ACQUISITION OF TRIALSTAT CLINICALANALYTICS
    View Article

  • November 17, 2008

    JUBILANT AUGMENTS CLINSYS CLINICAL RESEARCH® THROUGH ACQUISITION OF TRIALSTAT CLINICALANALYTICS®, AN EDC PLATFORM
    Download PDF | View Short Summary

    NOIDA, INDIA (November 17, 2008) - Jubilant Organosys Ltd. announced today that its subsidiary Clinsys Clinical Research, Inc.®, New Jersey, a global contract research organization (CRO), has acquired TrialStat ClinicalAnalytics® from TrialStat® for a purchase consideration of CAD 750,000.

    TrialStat ClinicalAnalytics (TrialStat CA) is a Web-based electronic data capture (EDC) solution currently used by a wide range of pharmaceutical and CRO customers worldwide. TrialStat CA is the industry's first EDC platform to allow all aspects of a study to be configured, deployed and managed through a browser interface, enabling customers to start their studies quickly and cost-effectively.

    Clinsys extensive global resources will enable TrialStat to continue its proven record of growth, customer service and product innovation. This agreement will give TrialStat's existing CRO and biopharmaceutical customer base a broader scope of services.

    "The Company had identified TrialStat ClinicalAnalytics as one of the most innovative EDC solutions on the market and was determined to include it in its offerings to its customers globally" said David E. Williams, Chief Executive Officer of Clinsys.

Upcoming Conferences